{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:49:55Z","timestamp":1791859795777,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bbr.2010.07.033","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T04:51:15Z","timestamp":1280897475000},"page":"186-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease"],"prefix":"10.1016","volume":"216","author":[{"given":"Jana\u00edna K.","family":"Barbiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronise M.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo M.S.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ariza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia H.","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Andreatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.B.F.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2010.07.033_bib0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJM199601113340202","article-title":"Prevalence of parkinsonian signs and associated mortality in a community population of older people","volume":"334","author":"Bennett","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbr.2010.07.033_bib0010","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbr.2010.07.033_bib0015","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2010.07.033_bib0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","article-title":"Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase","volume":"120","author":"Chiba","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bbr.2010.07.033_bib0025","first-page":"135","article-title":"The neurobiology of the substantia nigra pars compacta: from motor to sleep regulation","volume":"73","author":"Lima","year":"2009","journal-title":"J. Neural Transm Suppl"},{"key":"10.1016\/j.bbr.2010.07.033_bib0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.expneurol.2004.11.006","article-title":"Lesion of the substantia nigra, pars compacta impairs delayed alternation in a Y-maze in rats","volume":"192","author":"Braga","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2010.07.033_bib0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2008.07.022","article-title":"Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats","volume":"594","author":"Capitelli","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2010.07.033_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2010.07.033_bib0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1074-7427(03)00008-X","article-title":"Evidence for the substantia nigra pars compacta as an essential component of a memory system independent of the hippocampal memory system","volume":"79","author":"Da Cunha","year":"2003","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.bbr.2010.07.033_bib0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bbr.2010.07.033_bib0055","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1371\/journal.pone.0000513","article-title":"The role of the substantia nigra pars compacta in regulating sleep patterns in rats","volume":"2","author":"Lima","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbr.2010.07.033_bib0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.05.016","article-title":"Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats","volume":"1101","author":"Lima","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2010.07.033_bib0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jneumeth.2007.08.024","article-title":"Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease","volume":"167","author":"Reksidler","year":"2008","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bbr.2010.07.033_bib0070","first-page":"259","article-title":"Distinct Effects of Intranigral L-DOPA Infusion in the MPTP Rat Model of Parkinson's disease","volume":"73","author":"Reksidler","year":"2009","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.bbr.2010.07.033_bib0075","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1471-4159.2006.04327.x","article-title":"Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system","volume":"100","author":"Hunter","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2010.07.033_bib0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","article-title":"The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats","volume":"560","author":"Reksidler","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2010.07.033_bib0085","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2010.07.033_bib0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","article-title":"Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease","volume":"3","author":"Vijitruth","year":"2006","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bbr.2010.07.033_bib0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","article-title":"Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease","volume":"82","author":"Breidert","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2010.07.033_bib0100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/bjp.2008.78","article-title":"The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B","volume":"154","author":"Quinn","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2010.07.033_bib0105","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peroxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bbr.2010.07.033_bib0110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbr.2008.10.010","article-title":"Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease","volume":"197","author":"Kumar","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2010.07.033_bib0115","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.bbr.2010.07.033_bib0120","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","article-title":"Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease","volume":"81","author":"Gao","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2010.07.033_bib0125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha -beta, and -gamma in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2010.07.033_bib0130","first-page":"S103","article-title":"Effects of sleep deprivation on tyrosine hydroxylase expression and dopamine-related behaviors in two models of Parkinson's disease","volume":"8","author":"Lima","year":"2007","journal-title":"Sleep Medicine"},{"key":"10.1016\/j.bbr.2010.07.033_bib0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000136753","article-title":"Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain?","volume":"16","author":"Tufik","year":"1978","journal-title":"Pharmacology"},{"key":"10.1016\/j.bbr.2010.07.033_bib0140","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0026-0495(94)90173-2","article-title":"Regulation of glucose transport by pioglitazone in cultured muscle cells","volume":"43","author":"el-Kebbi","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.bbr.2010.07.033_bib0145","first-page":"13","article-title":"Pioglitazone: mechanism of action","volume":"121","author":"Smith","year":"2001","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/j.bbr.2010.07.033_bib0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0006-8993(84)90422-0","article-title":"Acute administration of 1-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a compound producing parkinsonism in humans, stimulates [2-14C]deoxyglucose uptake in the regions of the catecholaminergic cell bodies in the rat and guinea pig brains","volume":"301","author":"Palacios","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2010.07.033_bib0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(88)90162-X","article-title":"Administration of MPTP acutely increases glucose utilization in the substantia nigra of primates","volume":"453","author":"Palombo","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2010.07.033_bib0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000111335","article-title":"Sites and mechanisms of function-related changes in energy metabolism in the nervous system","volume":"15","author":"Sokoloff","year":"1993","journal-title":"Dev Neurosci"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432810005346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432810005346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:58:43Z","timestamp":1759064323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432810005346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0166432810005346"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2010.07.033","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2010.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}